| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5987445 | The Journal of Heart and Lung Transplantation | 2010 | 7 Pages |
Abstract
These preliminary data are the first to suggest that the improvement in renal function after switching to CNI-free everolimus treatment has the greatest potential within the first year post-HTx. While we await randomized, controlled trials, it appears that conversion can be performed with acceptable safety in selected patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Einar MD, Lars MD, PhD, Satish MD, Svein MD, PhD, Ina RN, Anders MD, PhD, Hallvard MD, PhD, Arnt E. MD, PhD, Odd R. MD, PhD, Arne K. MD, PhD,